Innovations and Challenges for Research Recruitment and Engagement To Be Discussed
FOR IMMEDIATE RELEASE: November 9, 2015
CONTACT: Amy West, 617-636-6025, email@example.com
BOSTON – Tufts Clinical and Translational Science Institute (CTSI) will host Translational Research Day: Innovations in Clinical Trial Participant Engagement, on Tuesday, November 10. The event brings together researchers, clinicians, community partners, and the public for:
- A keynote address by Karl D. Kieburtz, MD, MPH, Director of the Clinical and Translational Science Institute at the University of Rochester Medical Center. Dr. Kieburtz will talk about the development, dissemination, and use of mPower, a mobile application to track symptoms of Parkinson’s disease progression.
- Presentations and panel discussions by national leaders in clinical trials recruitment and participant engagement.
- An electronic poster session highlighting recent clinical and translational research.
- Breakout sessions on comparative effectiveness research grants, and on using research process improvement to solve recruitment challenges.
The agenda for the day is available at https://tuftsctsi.wpengine.com/events/translational-research-day-2015-innovations-in-clinical-trial-participant-engagement/. Members of the media are encouraged to attend.
This event is free and open to anyone who registers to attend. A live webcast will also be available.
WHO: Researchers, clinicians, community partners, students, and members of the public
WHAT: Translational Research Day 2015: Innovations in Clinical Trial Participant Engagement
WHEN: Tuesday, November 10, 8:30AM-4:00PM
WHERE: Tufts University School of Medicine, Center for Medical Education, Room 114, 145 Harrison Avenue, Boston
About Tufts Clinical and Translational Science Institute (CTSI)
Tufts CTSI, a National Institutes of Health (NIH)-supported partnership among all the schools and hospitals of Tufts University, Northeastern University, Brandeis University, RAND, and healthcare industry and community organizations, was established in August 2008. Its purpose is to accelerate the translation of laboratory and medical research into clinical use, widespread medical practice, and into improved healthcare delivery and health policy. It connects people to research resources, consultation, and education, and fosters collaboration with scholars of all disciplines and with community members, with the ultimate goal of improving the health of the public. Tufts CTSI is currently funded by the NIH National Center for Advancing Translational Sciences, award number UL1TR001064.